scorecardresearch
Add as a preferred source on Google
Wednesday, November 12, 2025
TopicSerum Institute India

Topic: Serum Institute India

No correlation between Covid vaccine trial & participant’s condition, says Serum Institute

ThePrint Team -
Participant in Covid vaccine trial sent legal notice to Serum Institute, claiming neurological & psychological symptoms, seeking Rs 5 crore in compensation.

SII plans to make 100 million vaccine doses a month by February, says Adar Poonawalla

ANI -
Poonawalla, CEO of the Serum Institute of India, disclosed that the pharma giant will apply for emergency authorisation of the Covid-19 vaccine in the next 2 weeks.

Alleging serious side-effects, vaccine trial participant seeks Rs 5 cr from Serum Institute

Himani Chandna -
Chennai-based participant also sends legal notice to ICMR, DCGI, AstraZeneca & Oxford University to stop testing, manufacturing & distributing vaccine.

AstraZeneca Covid vaccine effective, Indian trials running smoothly, says Serum Institute

PTI -
The comments came after AstraZeneca & Oxford University acknowledged a manufacturing error that is raising doubts about preliminary results of their experimental Covid-19 vaccine.

Serum Institute, ICMR complete enrolment for phase 3 trials of Oxford Covid vaccine

PTI -
SII and ICMR are currently conducting phase 2/3 clinical trials at 15 different centres across the country, with 1,600 participants.

Who should be first in line for India’s Covid vaccine? Lal Bahadur Shastri gave us a clue

Dr Anand Lakshman -
Health Minister Harsh Vardhan has said that 250 million Indians would be covered with a two-dose Covid-19 vaccine by July 2021.

Oxford vaccine trials running ‘smoothly’ in India, no adverse side-effects so far

Simrin Sirur -
In India, trials of the Oxford-AstraZeneca vaccine are being carried out by the Pune-based Serum Institute of India (SII) at 17 sites.

Serum Institute will deliver 10 crore more doses of Covid vaccine to India, other countries

Abantika Ghosh -
Pune-based Serum Institute of India has already committed to supplying 10 crore doses of the vaccine at a price of about Rs 225 per dose.

Will govt have Rs 80,000 crore to buy, distribute Covid vaccine, asks Serum Institute CEO

PTI -
Adar Poonawalla said there was a need to plan and guide vaccine manufacturers on procurement and distribution methods.

Phase-3 trial of Oxford vaccine to begin in Pune next week, volunteers start enrolling

PTI -
Earlier this month, the Serum Institute of India had paused the clinical trials of Oxford vaccine candidate in India. On 15 September, the DCGI gave permission to resume the trial.
1...4567Page 5 of 7

On Camera

YourTurn

Opinion

Air purifiers are the new water filters. Delhi has quietly accepted a crisis

Stela Dey -
The affluent in Delhi, armed with airtight windows, multiple purifiers, and humidifiers, have normalised a way of life that once seemed dystopian.

There’s a new M-Y formula at work in Bihar this time

Sitharaman’s eighth Budget faces fiscal headwinds — and a calendar dilemma

Economy

India’s factory data may get reality check in MoSPI’s new IIP plan, defunct factories to be dropped

Udit Bubna -
MoSPI proposes to remove closed factories from IIP sample, aiming for truer picture of India’s industrial health in upcoming 2022–23 base series. Plan open to public feedback until 25 November.

Defence

‘Let them see’: Putin says new nuclear-powered missiles in the making, in message to Washington

Keshav Padmanabhan -
At a ceremony felicitating Russian military engineers, Putin highlights Moscow’s 'parity' in defence technologies for the next century.

National Interest

Bihar is where politics moves, and everything else stands still

Shekhar Gupta -
Bihar is blessed with a land more fertile for revolutions than any in India. Why has it fallen so far behind then? Constant obsession with politics is at the root of its destruction.

Follow us

Copyright © 2025 Printline Media Pvt. Ltd. All rights reserved.